These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 26276305)
21. Validity and reliability of a Severity of Dependence Scale for khat (SDS-khat). Kassim S; Islam S; Croucher R J Ethnopharmacol; 2010 Dec; 132(3):570-7. PubMed ID: 20837124 [TBL] [Abstract][Full Text] [Related]
22. Clozapine-induced severe mixed hyperlipidemia: a case report. Ahmed M; Griffin D; O'Toole R; McDonald C Gen Hosp Psychiatry; 2009; 31(1):93-6. PubMed ID: 19134516 [TBL] [Abstract][Full Text] [Related]
23. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine. Krzystanek M; Krupka-Matuszczyk I Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416 [TBL] [Abstract][Full Text] [Related]
24. Clinical validation of the self-reported Glasgow Antipsychotic Side-effect Scale using the clinician-rated UKU side-effect scale as gold standard reference. Schouby Bock M; Nørgaard Van Achter O; Dines D; Simonsen Speed M; Correll CU; Mors O; Østergaard SD; Kølbæk P J Psychopharmacol; 2020 Aug; 34(8):820-828. PubMed ID: 32500804 [TBL] [Abstract][Full Text] [Related]
25. Patients' and primary carers' views on clozapine treatment for schizophrenia: A cross-sectional study in Qatar. Srour A; Eltorki Y; Malik H; Alabdulla MA; Hassan MHMO; Ahmed Al Subaiey M; Michael Haddad P Saudi Pharm J; 2023 Feb; 31(2):214-221. PubMed ID: 36942276 [TBL] [Abstract][Full Text] [Related]
26. Reliability and Validation of the International Consultation on Incontinence Questionnaire in Over Active Bladder to Persian Language. Sari Motlagh R; Hajebrahimi S; Sadeghi-Bazargani H; Joodi Tutunsaz J Low Urin Tract Symptoms; 2015 May; 7(2):99-101. PubMed ID: 26663689 [TBL] [Abstract][Full Text] [Related]
27. Comprehensive assessment of exposure to clozapine in association with side effects among patients with treatment-resistant schizophrenia: a population pharmacokinetic study. Nomura N; Kitagawa K; So R; Misawa F; Kodama M; Takeuchi H; Bies R; Straubinger T; Banker C; Mizuno Y; Mimura M; Uchida H Ther Adv Psychopharmacol; 2021; 11():20451253211016189. PubMed ID: 34046160 [TBL] [Abstract][Full Text] [Related]
28. Clozapine-induced tardive dyskinesia in schizophrenic patients taking clozapine as a first-line antipsychotic drug. Li CR; Chung YC; Park TW; Yang JC; Kim KW; Lee KH; Hwang IK World J Biol Psychiatry; 2009; 10(4 Pt 3):919-24. PubMed ID: 19995222 [TBL] [Abstract][Full Text] [Related]
29. Validation in Spanish population of the family objective and subjective burden interview (ECFOS-II) for relatives of patients with schizophrenia. Vilaplana M; Ochoa S; Martinez A; Villalta V; Martinez-Leal R; Puigdollers E; Salvador L; Martorell A; Muñoz PE; Haro JM; Actas Esp Psiquiatr; 2007; 35(6):372-81. PubMed ID: 17597427 [TBL] [Abstract][Full Text] [Related]
30. Aripiprazole augmentation in the management of residual symptoms in clozapine-treated outpatients with chronic schizophrenia: An open-label pilot study. Mitsonis CI; Dimopoulos NP; Mitropoulos PA; Kararizou EG; Katsa AN; Tsakiris FE; Katsanou MN Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):373-7. PubMed ID: 17092620 [TBL] [Abstract][Full Text] [Related]
31. Reliability and validity of COOP/WONCA functional health status charts for stroke patients in primary care. Lennon OC; Carey A; Creed A; Durcan S; Blake C J Stroke Cerebrovasc Dis; 2011; 20(5):465-73. PubMed ID: 20813545 [TBL] [Abstract][Full Text] [Related]
32. The side effects of antipsychotic drugs and patients' quality of life: patient education and preference assessment with computers and multimedia. Morss SE; Lenert LA; Faustman WO Proc Annu Symp Comput Appl Med Care; 1993; ():17-21. PubMed ID: 7907504 [TBL] [Abstract][Full Text] [Related]
35. Lack of extrapyramidal side effects predicts quality of life in outpatients treated with clozapine or with typical antipsychotics. Strejilevich SA; Palatnik A; Avila R; Bustin J; Cassone J; Figueroa S; Gimenez M; de Erausquin GA Psychiatry Res; 2005 Feb; 133(2-3):277-80. PubMed ID: 15741003 [TBL] [Abstract][Full Text] [Related]
36. Is clonidine useful for treatment of clozapine-induced sialorrhea? Praharaj SK; Verma P; Roy D; Singh A J Psychopharmacol; 2005 Jul; 19(4):426-8. PubMed ID: 15983000 [TBL] [Abstract][Full Text] [Related]
37. Higher plasma drug concentration in clozapine-treated schizophrenic patients with side effects of obsessive/compulsive symptoms. Lin SK; Su SF; Pan CH Ther Drug Monit; 2006 Jun; 28(3):303-7. PubMed ID: 16778711 [TBL] [Abstract][Full Text] [Related]
38. The safety of clozapine in the treatment of first- and multiple-episode patients with treatment-resistant schizophrenia. Hofer A; Hummer M; Kemmler G; Kurz M; Kurzthaler I; Fleischhacker WW Int J Neuropsychopharmacol; 2003 Sep; 6(3):201-6. PubMed ID: 12974985 [TBL] [Abstract][Full Text] [Related]
39. [Validation of a French adaptation of the international prostatic symptom score]. Grégoire JP; Moisan J; Labrecque M; Cusan L; Diamond P Prog Urol; 1996 Apr; 6(2):240-9. PubMed ID: 8777417 [TBL] [Abstract][Full Text] [Related]
40. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial. Barbui C; Accordini S; Nosè M; Stroup S; Purgato M; Girlanda F; Esposito E; Veronese A; Tansella M; Cipriani A; J Clin Psychopharmacol; 2011 Jun; 31(3):266-73. PubMed ID: 21508849 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]